HPV16 is the subtype most frequently associated with HNC, and current clinically relevant detection methods focus on identifying the presence of HPV16 by PCR or ISH, or detection of p16 protein expression in tumour samples by IHC. The gene discussed is CDKN2A; the disease is neoplasm.